MEDICORE CO., LTD.
TaiwanKorea, Republic of4 products registeredMar 02, 2006 – Oct 30, 2024
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Total products
4
Product types
3
Active products
Oct 2024
Latest registration
Company details
- Address
- No.801-803, Joonganginnotech, 148, Sagimakgol-ro, Jungwon-Gu, Seongnam-Si, Gyunggi-do, Korea
Regulatory footprint
Search MEDICORE CO., LTD. across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
"Medicobino" Infrared Thermal Imaging System (Non-Sterilized)
Registered: Oct 30, 2024 • Expires: Oct 30, 2029
- Risk Class
- Class 1
- AR
- Beno International S.A
“MEDICORE” Heart Rate Variability Analysis Equipment
Registered: Jul 31, 2018 • Expires: Jul 31, 2028
- Risk Class
- Class 2
- Type
- MD
- AR
- NEWAED WORLDWIDE PROCUREMENT CONGLOMERATE CORPORATION
"Hetian" infrared imaging system
Registered: Jan 07, 2008 • Expires: Jan 07, 2013
Cancelled
- Risk Class
- Class 3
- AR
- WATON INTERNATIONAL CO., LTD.
"Medico" heart rate variability analyzer
Registered: Mar 02, 2006 • Expires: Mar 02, 2026
- Risk Class
- Class 2
- AR
- WATON INTERNATIONAL CO., LTD.
About this profile
Explore comprehensive manufacturer profile for MEDICORE CO., LTD. based in Korea, Republic of through Pure Global AI's free Taiwan medical device database. This manufacturer has 4 products registered in Taiwan across 4 unique product categories. Their regulatory history spans from Mar 02, 2006 to Oct 30, 2024.
This page provides detailed insights including 4 recent product registrations, 4 most popular products with "Medicobino" Infrared Thermal Imaging System (Non-Sterilized) having 1 registrations, and 3 authorized representatives including WATON INTERNATIONAL CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.